| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.63▲ | 1.61▲ | 1.61▲ | 1.56▲ | 1.55▲ |
| MA10 | 1.61▲ | 1.60▲ | 1.59▲ | 1.52▲ | 1.59▲ |
| MA20 | 1.58▲ | 1.56▲ | 1.55▲ | 1.52▲ | 1.67▼ |
| MA50 | 1.54▲ | 1.55▲ | 1.56▲ | 1.59▲ | 2.29▼ |
| MA100 | 1.62▲ | 1.66▼ | 1.67▼ | 1.69▼ | 3.10▼ |
| MA200 | 1.70▼ | 1.73▼ | 1.76▼ | 1.98▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.011▲ | 0.015▲ | 0.022▲ | 0.037▲ |
| RSI | 70.958▲ | 68.172▲ | 65.400▲ | 64.813▲ | 41.873▼ |
| STOCH | 100.000▲ | 98.551▲ | 97.757▲ | 86.712▲ | 22.281 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | -61.899 |
| CCI | 106.944▲ | 103.349▲ | 97.558 | 240.333▲ | -22.430 |
|
Wednesday, April 30, 2025 01:05 PM
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious ...
|
|
Tuesday, April 29, 2025 12:26 PM
Viking Therapeutics (NASDAQ:VKTX) and other developers of oral weight loss drugs traded sharply higher on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla indicated plans to seek deals to add ...
|
|
Tuesday, April 29, 2025 12:26 PM
Viking Therapeutics (NASDAQ:VKTX) and other developers of oral weight loss drugs traded sharply higher on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla indicated plans to seek deals to add ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.59 | 1.67 | 1.58 | 1.67 | 12,353 |
| 30/04/25 | 1.585 | 1.5985 | 1.58 | 1.58 | 5,357 |
| 29/04/25 | 1.51 | 1.52 | 1.485 | 1.52 | 8,350 |
| 28/04/25 | 1.50 | 1.55 | 1.50 | 1.55 | 5,371 |
| 25/04/25 | 1.49 | 1.51 | 1.49 | 1.50 | 9,232 |
| 24/04/25 | 1.46 | 1.50 | 1.4506 | 1.485 | 10,968 |
| 23/04/25 | 1.46 | 1.4899 | 1.46 | 1.47 | 4,348 |
| 22/04/25 | 1.49 | 1.4992 | 1.46 | 1.47 | 9,947 |
| 21/04/25 | 1.49 | 1.5044 | 1.4535 | 1.47 | 6,714 |
| 17/04/25 | 1.4627 | 1.51 | 1.43 | 1.50 | 3,071 |
|
|
||||
|
|
||||
|
|